Your browser doesn't support javascript.
loading
TP53 K351N mutation-associated platinum resistance after neoadjuvant chemotherapy in patients with advanced ovarian cancer.
Zhang, Guo-nan; Liu, Hong; Huang, Jian-ming; Wang, Ling; Zhao, Jing-sha; Li, Chao; Mi, Kun; Zhu, Yi; Cheng, Jia; Zha, Xiao.
Afiliação
  • Zhang GN; Department of Gynaecologic Oncology, Sichuan Cancer Hospital, Chengdu, Sichuan, PR China; Graduate School, Guangxi Medical University, Nanning, Guangxi, PR China; Graduate School, Luzhou Medical College, Luzhou, Sichuan, PR China.
  • Liu H; Department of Gynaecologic Oncology, Sichuan Cancer Hospital, Chengdu, Sichuan, PR China.
  • Huang JM; Department of Biochemistry & Molecular Biology, Sichuan Cancer Institute, Chengdu, Sichuan, PR China. Electronic address: wesleyhuangcn2002@163.com.
  • Wang L; Department of Gynaecologic Oncology, Sichuan Cancer Hospital, Chengdu, Sichuan, PR China; Graduate School, Guangxi Medical University, Nanning, Guangxi, PR China.
  • Zhao JS; Department of Gynaecologic Oncology, Sichuan Cancer Hospital, Chengdu, Sichuan, PR China; Graduate School, Luzhou Medical College, Luzhou, Sichuan, PR China.
  • Li C; Department of Gynaecologic Oncology, Sichuan Cancer Hospital, Chengdu, Sichuan, PR China; Graduate School, Guangxi Medical University, Nanning, Guangxi, PR China.
  • Mi K; Department of Biochemistry & Molecular Biology, Sichuan Cancer Institute, Chengdu, Sichuan, PR China.
  • Zhu Y; Department of Gynaecologic Oncology, Sichuan Cancer Hospital, Chengdu, Sichuan, PR China; Department of Ultrasound, Sichuan Cancer Hospital, Chengdu, Sichuan, PR China.
  • Cheng J; Department of Biochemistry & Molecular Biology, Sichuan Cancer Institute, Chengdu, Sichuan, PR China.
  • Zha X; Department of Biochemistry & Molecular Biology, Sichuan Cancer Institute, Chengdu, Sichuan, PR China.
Gynecol Oncol ; 132(3): 752-7, 2014 Mar.
Article em En | MEDLINE | ID: mdl-24463159

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Protocolos de Quimioterapia Combinada Antineoplásica / Proteína Supressora de Tumor p53 / Neoplasias Epiteliais e Glandulares / Mutação de Sentido Incorreto Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Protocolos de Quimioterapia Combinada Antineoplásica / Proteína Supressora de Tumor p53 / Neoplasias Epiteliais e Glandulares / Mutação de Sentido Incorreto Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2014 Tipo de documento: Article